"Subsequent to June 30, 2016, in accordance with the terms and conditions of the executed Global LOI, the Company deemed the Global LOI terminated. Pursuant to the termination under the agreement, Global is obligated to issue to the Company that number of shares of Global’s common stock equal to 10% of the then outstanding shares of Global’s common stock, on a fully-diluted basis, as payment of the Global Advance."
10% of GCDx stock? That must be worth at least a quadrazillion dollars since GCDx is merging with Radient and Provista as part of a Global SuperPower MegaPharma. Right? That's still the story, a Creative Backdoor Multi Merger of some kind, with William as the Grand Poobah?
In addition to the share issuance, the Company is evaluating certain additional remedies related to the Global LOI and the $50,000 advance."
Good luck getting your $50,000 back, QuantRx. Seriously, what good is 10% of GCDx stock? Nobody would buy it.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.